Alloimmune-mediated vascular remodeling of human coronary artery grafts in immunodeficient mouse recipients is independent of preexisting atherosclerosis

Transplantation

Volumn 83, Issue 11, 2007, Pages 1501-1505

  Wang, Yinong ^a   Ahmad, Usman ^a   Yi, Tai ^a   Zhao, Liping ^a   Lorber, Marc I ^a   Pober, Jordan S ^a   Tellides, George ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Coronary artery; Graft arteriosclerosis; Intima; Vascular remodeling

Indexed keywords

ADULT; AGED; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL; CARDIAC ALLOGRAFT VASCULOPATHY; CHIMERA; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; EXPERIMENTAL STUDY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; ANIMALS; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; GRAFT REJECTION; HUMANS; MALE; MICE; MICE, SCID; MIDDLE AGED; TRANSPLANTATION CHIMERA; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HETEROLOGOUS;

EID: 34250680105     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000264560.51845.67     Document Type: Article

References (27)

1. Billingham ME. Cardiac transplant atherosclerosis. Transplant Proc 1987; 19(4 Suppl 5): 19.
2. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371.
3. Hermiller JB, Tenaglia AN, Kisslo KB, et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993; 71: 665.
4. Pethig K, Heublein B, Wahlers T, Haverich A. Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate vascular remodeling rather than intimal hyperplasia is the major predictor of coronary artery stenosis. Working Group on Cardiac Allograft Vasculopathy. Am Heart J 1998; 135: 628.
5. Mainigi SK, Goldberg LR, Sasseen BM, et al. Relative contributions of intimal hyperplasia and vascular remodeling in early cardiac transplant-mediated coronary artery disease. Am J Cardiol 2003; 91: 293.
6. Lorber MI, Wilson JH, Robert ME, et al. Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice. Transplantation 1999; 67: 897.
7. Wang Y, Burns WR, Tang PC, et al. Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J 2004; 18: 606.
8. Koh KP, Wang Y, Yi T, et al. T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. J Clin Invest 2004; 114: 846.
9. Kapadia SR, Nissen SE, Ziada KM, et al. Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging. Circulation 1998; 98: 2672.
10. Wong C, Ganz P, Miller L, et al. Role of vascular remodeling in the pathogenesis of early transplant coronary artery disease: A multicenter prospective intravascular ultrasound study. J Heart Lung Transplant 2001; 20: 385.
11. Botas J, Pinto FJ, Chenzbraun A, et al. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation 1995; 92: 1126.
12. Wong CK, Yeung AC. The topography of intimal thickening and associated remodeling pattern of early transplant coronary disease: Influence of pre-existent donor atherosclerosis. J Heart Lung Transplant 2001; 20: 858.
13. Li H, Tanaka K, Anzai H, et al. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients. J Am Coll Cardiol 2006; 47: 2470.
14. Gao HZ, Hunt SA, Alderman EL, et al. Relation of donor age and preexisting coronary artery disease on angiography and intracoronary ultrasound to later development of accelerated allograft coronary artery disease. J Am Coll Cardiol 1997; 29: 623.
15. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 2006; 25: 869.
16. Mehra MR, Stapleton DD, Ventura HO, et al. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study. Circulation 1994; 90: II78.
17. Erinc K, Yamani MH, Starling RC, et al. The influence of donor gender on allograft vasculopathy: Evidence from intravascular ultrasound. Transplant Proc 2004; 36: 3129.
18. Herity NA, Lo S, Lee DP, et al. Effect of a change in gender on coronary arterial size: A longitudinal intravascular ultrasound study in transplanted hearts. J Am Coll Cardiol 2003; 41: 1539.
19. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation-rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: 244.
20. Whitman SC, Ravisankar P, Daugherty A. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice. J Interferon Cytokine Res 2002; 22: 661.
21. Peugh WN, Superina RA, Wood KJ, Morris PJ. The role of H-2 and non-H-2 antigens and genes in the rejection of murine cardiac allografts. Immunogenetics 1986; 23: 30.
22. Bosma MJ, Carroll AM. The SCID mouse mutant: Definition, characterization, and potential uses. Annu Rev Immunol 1991; 9: 323.
23. Russell PS, Chase CM, Colvin RB. Accelerated atheromatous lesions in mouse hearts transplanted to apolipoprotein-E-deficient recipients. Am J Pathol 1996; 149: 91.
24. Llodra J, Angeli V, Liu J, et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci USA 2004; 101: 11779.
25. Pober JS, Bothwell AL, Lorber MI, et al. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse. Springer Semin Immunopathol 2003; 25: 167.
26. Yi T, Cuchara L, Wang Y, et al. Human allograft arterial injury is ameliorated by sirolimus and cyclosporine and correlates with suppression of interferon-gamma. Transplantation 2006; 81: 559.
27. Tellides G, Tereb DA, Kirkiles-Smith NC, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000; 403: 207.